Business
The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials
CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), a pioneer in value-based community oncology care, is proud to announce an enterprise-wide expansion of its strategic partnership with Helios Clinical Research, a nationally recognized research site network. This initiative builds upon a successful collaboration in Florida and reflects TOI’s ongoing commitment to integrating clinical research into community oncology settings.
About this update from The Oncology Institute, Inc.
[{"type":"image","alt":"Toi Management, LLC","displaySize":"","headline":null,"caption":"Toi Management, LLC","className":"","disableSlideshowImg":false,"size":{"original":{"width":248,"height":86,"url":"https://media.zenfs.com/en/globenewswire.com/38271848c3d8a5e1e22cde43512eba2e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yhdVXLCOU06mfTSW3.iIsg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0NjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/38271848c3d8a5e1e22cde43512eba2e","width":248,"height":86}},"lazy":false},{"type":"text","content":"CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), a pioneer in value-based community oncology care, is proud to announce an enterprise-wide expansion of its strategic partnership with Helios Clinical Research, a nationally recognized research site network. This initiative builds upon a successful collaboration in Florida and reflects TOI’s ongoing commitment to integrating clinical research into community oncology settings.","length":499,"tagName":"p"},{"type":"text","content":"“Expanding our research collaboration with Helios Clinical is a natural next step,” said Daniel Virnich, MD, CEO at TOI. “They’ve proven to be a highly capable partner, helping us streamline study activation, accelerate enrollment, and reduce operational burden on our sites. This move allows us to scale our research infrastructure much more quickly while staying laser-focused on patient care.”","length":396,"tagName":"p"},{"type":"text","content":"Strategic Benefits of the Partnership:","length":38,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Expanded Access to Clinical Trials: Patients will gain greater access to leading-edge therapies through trials supported by Helios’ centralized operations and outreach model.","length":174,"tagName":"p"}]},{"val":[{"type":"text","content":"Enhanced Trial Performance: Sponsors benefit from streamlined startup processes, optimized patient matching, and unified oversight.","length":131,"tagName":"p"}]},{"val":[{"type":"text","content":"Scalable Infrastructure: Helios provides regulatory, recruitment, and operational support, enabling TOI’s clinicians to focus on delivering world-class care while expanding their research footprint.","length":198,"tagName":"p"}]},{"val":[{"type":"text","content":"Equity in...